APA

Luo D., Fraga-Lauhirat M., Millings J., Ho C., Villarreal E. M., Fletchinger T. C., Bonfiglio J. V., Mata L., Nemesure M. D., Bartels L. E., Wang R., Rigas B. & Mackenzie G. G. (20200527). Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation. : Carcinogenesis.

Chicago

Luo Dingyuan, Fraga-Lauhirat Magdalena, Millings Jonathan, Ho Cristella, Villarreal Emily M, Fletchinger Teresa C, Bonfiglio James V, Mata Leyda, Nemesure Matthew D, Bartels Lauren E, Wang Ruixue, Rigas Basil and Mackenzie Gerardo G. 20200527. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation. : Carcinogenesis.

Harvard

Luo D., Fraga-Lauhirat M., Millings J., Ho C., Villarreal E. M., Fletchinger T. C., Bonfiglio J. V., Mata L., Nemesure M. D., Bartels L. E., Wang R., Rigas B. and Mackenzie G. G. (20200527). Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation. : Carcinogenesis.

MLA

Luo Dingyuan, Fraga-Lauhirat Magdalena, Millings Jonathan, Ho Cristella, Villarreal Emily M, Fletchinger Teresa C, Bonfiglio James V, Mata Leyda, Nemesure Matthew D, Bartels Lauren E, Wang Ruixue, Rigas Basil and Mackenzie Gerardo G. Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation. : Carcinogenesis. 20200527.